Small Particles, Big Potential: Polymeric Nanoparticles for Drug Delivery in Parkinson's Disease
Movement Disorders · 2024-11 · 39 (11) · 1922-1937
DOI: 10.1002/mds.29939 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Movement Disorders, online erschienen am 30.07.2024. Verfasst von Sasivimol Virameteekul und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Parkinson Disease, Polymers, Nanoparticle Drug Delivery System. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 143 Literaturangaben.
Abstract (Originalsprache)
Despite the availability of a number of efficacious treatments for Parkinson's disease, their limitations and drawbacks, particularly related to low brain bioavailability and associated side effects, emphasize the need for alternative and more effective therapeutic approaches. Nanomedicine, the application of nanotechnology in medicine, has received considerable interest in recent years as a method of effectively delivering potentially therapeutic molecules to the brain. In particular, polymeric nanoparticles, constructed from biodegradable polymer, have shown great promise in enhancing therapeutic efficacy, reducing toxicity, and ensuring targeted delivery. However, their clinical translation remains a considerable challenge. This article reviews recent in vitro and in vivo studies using polymeric nanoparticles as drug and gene delivery systems for Parkinson's disease with their challenges and future directions. We are also particularly interested in the technical properties, mechanism, drugs release patterns, and delivery strategies to overcome the blood–brain barrier. © 2024 International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
- Reta Lila Weston Institute of Neurological Studies, UCL Queen Square Institute of Neurology, London, UK.
- Chulalongkorn Centre of Excellence for Parkinson's Disease and Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, B…
- The Academy of Science, The Royal Society of Thailand, Bangkok, Thailand.
ORCID-Profile: Sasivimol Virameteekul, Andrew J Lees, Roongroj Bhidayasiri
Zitieren
APA
Virameteekul, S., Lees, A. J., & Bhidayasiri, R. (2024). Small Particles, Big Potential: Polymeric Nanoparticles for Drug Delivery in Parkinson's Disease. Movement Disorders, 39(11), 1922-1937. https://doi.org/10.1002/mds.29939
Vancouver
Virameteekul S, Lees AJ, Bhidayasiri R. Small Particles, Big Potential: Polymeric Nanoparticles for Drug Delivery in Parkinson's Disease. Movement Disorders. 2024;39(11):1922-1937. doi:10.1002/mds.29939
BibTeX
@article{Virameteekul2024,
author = {Virameteekul, Sasivimol and Lees, Andrew J and Bhidayasiri, Roongroj},
title = {Small Particles, Big Potential: Polymeric Nanoparticles for Drug Delivery in Parkinson's Disease},
journal = {Movement Disorders},
year = {2024},
volume = {39},
number = {11},
pages = {1922--1937},
doi = {10.1002/mds.29939}
}
EUVIMED